InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-12.6%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by NEWHALL CHARLES W III, Director. Insider active across 1 company, notably Supernus Pharmaceuticals, INC.. In total, 9 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €2.1m. Activity tracked since 19 February 2022. The latest transaction was disclosed on 9 October 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
23,800 shares@ US$50.7350.0% of flowCommon StockSEC:0001628280-25-044797
23,800 shares@ US$50.730.037% mcap50.0% of flowCommon StockSEC:0001628280-25-044797:0
5,369 shares0Common StockSEC:0001628280-25-007476:0
20,000 shares@ US$9.137.1% of flowCommon StockSEC:0001628280-24-047155:0
3,886 shares0Common StockSEC:0001104659-24-028281:0
7,457 shares@ US$9.242.7% of flowCommon StockSEC:0001104659-23-119962:0
3,882 shares0Common StockSEC:0001104659-23-025374:0
8,722 shares@ US$7.902.7% of flowCommon StockSEC:0001104659-22-131398:0
4,222 shares0Common StockSEC:0001104659-22-026109:0
9 of 9 declarations
About NEWHALL CHARLES W III
Charles W. Newhall III is a Director of SUPERNUS PHARMACEUTICALS, INC. He plays a key role in the strategic direction of the company, ensuring that decisions made align with growth and innovation objectives.
